Search filters

List of works by Christopher Melani

Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study

scientific article published on 01 December 2018

End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making

scientific article published on 10 May 2018

Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma

scientific article published on 30 March 2020

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

scientific article published on 10 May 2017

MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R.

scientific article published on 22 June 2017

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

scientific article published on 26 May 2020

PD-1 Blockade in Mediastinal Gray-Zone Lymphoma.

scientific article published in July 2017

Pathobiology and Treatment of Lymphomatoid Granulomatosis; A Rare EBV-Driven Disorder

scientific article published on 27 February 2020

Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomas

scientific article published on 10 January 2019

Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas.

scientific article published on 16 October 2017

What is the standard of care for primary mediastinal b-cell lymphoma; R-CHOP or DA-EPOCH-R?

scientific article published on 13 March 2018

Paulina is supported by:

About Paulina

Help